- Home
- AGI vs TECH Comparison
AGI vs TECH Comparison
Compare AGI & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGI
- TECH
- Stock Information
- Founded
- AGI 2003
- TECH 1976
- Country
- AGI Canada
- TECH United States
- Employees
- AGI N/A
- TECH N/A
- Industry
- AGI Precious Metals
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AGI Basic Materials
- TECH Health Care
- Exchange
- AGI Nasdaq
- TECH Nasdaq
- Market Cap
- AGI 7.7B
- TECH 8.0B
- IPO Year
- AGI 1999
- TECH 1989
- Fundamental
- Price
- AGI $29.58
- TECH $48.10
- Analyst Decision
- AGI Buy
- TECH Buy
- Analyst Count
- AGI 5
- TECH 9
- Target Price
- AGI $27.90
- TECH $81.25
- AVG Volume (30 Days)
- AGI 4.2M
- TECH 2.2M
- Earning Date
- AGI 04-30-2025
- TECH 05-07-2025
- Dividend Yield
- AGI 0.34%
- TECH 0.63%
- EPS Growth
- AGI 30.19
- TECH N/A
- EPS
- AGI 0.69
- TECH 0.98
- Revenue
- AGI $1,346,900,000.00
- TECH $1,196,016,000.00
- Revenue This Year
- AGI $26.96
- TECH $8.19
- Revenue Next Year
- AGI N/A
- TECH $8.85
- P/E Ratio
- AGI $43.67
- TECH $49.09
- Revenue Growth
- AGI 31.62
- TECH 4.46
- 52 Week Low
- AGI $14.31
- TECH $46.44
- 52 Week High
- AGI $31.00
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- AGI 68.19
- TECH 33.97
- Support Level
- AGI $28.44
- TECH $46.44
- Resistance Level
- AGI $31.00
- TECH $53.00
- Average True Range (ATR)
- AGI 1.32
- TECH 3.30
- MACD
- AGI 0.31
- TECH -0.27
- Stochastic Oscillator
- AGI 81.09
- TECH 13.00
About AGI Alamos Gold Inc.
Alamos Gold Inc acquires, explores, and produces gold and other precious metals, and operates in two principal geographic areas: Canada and Mexico. The company has three operating mines in North America: Young-Davidson and Island Gold mines operate in Canada and the Mulatos and in Sonora, Mexico. The company generates maximum revenue from the Mulatos mines.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.